DJIA 17,164.95 -251.90 -1.45%
NASDAQ 4,635.24 -48.17 -1.03%
S&P 500 1,994.99 -26.26 -1.30%
market minute promo

33.66 -0.69 (-2.01%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NBIX $33.66 -2.01%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $34.20
Previous Close $34.35
Daily Range $33.62 - $35.00
52-Week Range $12.17 - $35.00
Market Cap $2.6B
P/E Ratio -47.71
Dividend (Yield) $0.00 (0.0%)
Volume 985,294
Average Daily Volume 1,371,164
Current FY EPS -$0.80

Sector

Healthcare

Industry

Drugs

Neurocrine Biosciences, Inc. (NBIX) Description

Discovers, develops and intend to commercialize drugs for the treatment of neurological and endocrine-related diseases and disorders. Product candidates will target insomnia, anxiety, depression, cancer, diabetes, and multiple sclerosis. Website: http://www.neurocrine.com/

News & Commentary

Cancel JPMorgan! Plenty of Pre-Conference Data and Deals to Digest

The week before JPMorgan Healthcare conference brought a plethora of deals and data.

Stocks Hitting 52-Week Highs

Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 4

Neurocrine Biosciences Starts A Data-Rich Year On The Right Foot

Why Neurocrine Biosciences, Inc. Shares Took Off Today

Is this meaningful? Or just another movement?

Mid-Morning Market Update: Markets Jump; Family Dollar Profit Misses Estimates

Mid-Morning Market Update: Markets Jump; Family Dollar Profit Misses Estimates

Benzinga's Volume Movers

6 Serious Biotech and Health Care Movers

Our 3 Best Performing Stocks Of 2014

See More NBIX News...

NBIX's Top Competitors

NBIX $33.66 (-2.01%)
Current stock: NBIX
AMGN $152.26 (-2.63%)
Current stock: AMGN
GILD $104.83 (0.62%)
Current stock: GILD
BIIB $389.16 (10.17%)
Current stock: BIIB